Experiments on mice suggest that an approach called antisense oligonucleotide therapy may be able to treat some symptoms of Angelman syndrome, including problems with epilepsy and sleep.
Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.
Read the full paper
Access the original peer-reviewed research via PubMed.
| Category | 🧬 Medicine & Biology |
| Published | Feb 07, 2023 |
| Journal | eLife |
| Authors | Reiter Lawrence T |
| DOI | 10.7554/eLife.86117 |
| Source | PubMed |